# Euclidean Capital LLC: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 1825034.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $439.8m
- Positions: 11 (11 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1825034/000101297526000776/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| VANGUARD INTL EQUITY INDEX F | ALLWRLD EX US | $271.6m | 61.8% | 3,243,484 |  | Unchanged |
| VANGUARD INDEX FDS | VALUE ETF | $113.3m | 25.8% | 520,000 |  | Unchanged |
| ISHARES TR | MSCI INDIA ETF | $18.3m | 4.2% | 369,600 |  | Unchanged |
| [ORIC PHARMACEUTICALS INC (ORIC)](/companies/oric.md) | COM | $10.7m | 2.4% | 989,410 |  | Unchanged |
| [TEAMSHARES INC (TMS)](/companies/tms.md) | COM | $9.0m | 2.1% | 1,099,974 |  | New +1,099,974 |
| [FOGHORN THERAPEUTICS INC (FHTX)](/companies/fhtx.md) | COM | $7.7m | 1.7% | 1,573,761 |  | Unchanged |
| [PMV PHARMACEUTICALS INC (PMVP)](/companies/pmvp.md) | COM | $3.5m | 0.8% | 2,627,643 |  | Unchanged |
| [ALECTOR INC (ALEC)](/companies/alec.md) | COM | $2.6m | 0.6% | 1,307,858 |  | Unchanged |
| [SURROZEN INC (SRZN)](/companies/srzn.md) | COM NEW | $2.3m | 0.5% | 87,696 |  | Unchanged |
| [TENAYA THERAPEUTICS INC (TNYA)](/companies/tnya.md) | COM | $750.7k | 0.2% | 1,015,705 |  | Unchanged |
| SURROZEN INC | \*W EXP 08/01/203 | $2.8k | <0.1% | 170,833 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0001012975-26-000776. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.